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OBJECTIVE: Depression is the most important neuropsychiatric complication in chronic kidney disease because it
reduces quality of life and increases mortality. Evidence demonstrating the association between dialysis shift
and depression is lacking; thus, obtaining such evidence was the main objective of this study.
METHOD: This cross-sectional study included patients attending a hemodialysis program. Depression was
diagnosed using Beck’s Depression Inventory. Excessive daytime sleepiness was evaluated using the Epworth
Sleepiness Scale.
RESULTS: A total of 96 patients were enrolled (55 males, age 48¡14 years). Depression and excessive daytime
sleepiness were observed in 42.7% and 49% of the patients, respectively. When comparing variables among the
three dialysis shifts, there were no differences in age, dialysis vintage, employment status, excessive daytime
sleepiness, hemoglobin, phosphorus levels, or albumin levels. Patients in the morning shift were more likely to
live in rural areas (p,0.0001), although patients in rural areas did not have a higher prevalence of depression
(p=0.30). Patients with depression were more likely to be dialyzed during the morning shift (p=0.008).
Independent risk factors for depression were age (p,0.03), lower levels of hemoglobin (p,0.01) and
phosphorus (p,0.01), and dialysis during the morning shift (p=0.0009). The hospitalization risk of depressive
patients was 4.5 times higher than that of nondepressive patients (p,0.008).
CONCLUSION: These data suggest that depression is associated with dialysis shift, higher levels of phosphorus,
and lower levels of hemoglobin. The results highlight the need for randomized trials to determine whether this
association occurs by chance or whether circadian rhythm disorders may play a role.
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& INTRODUCTION
Chronic Kidney Disease (CKD) is a silent disease that is
frequently diagnosed in the advanced stages when dialysis
and renal transplantation are the only options. The beginning
of dialysis treatment causes subtle changes in the life of CKD
patients, mainly in the physical and social spheres. For this
reason, individuals diagnosed with CKD usually develop
neuropsychiatric complications. Depression is the most
important of them, due to its high prevalence, reduction in
quality of life, and potential to increase mortality (1,2). The
prevalence of depression in CKD patients, even those in the
predialysis stages, is higher than that reported for the general
population and for individuals with other chronic diseases
(1,2). Depressive patients with CKD on hemodialysis have a
higher risk of death and hospitalizations compared with
those without depressive symptoms (3). Despite the high
prevalence (60% in some series) and damaging conse-
quences, depression is still a misdiagnosed disorder because
of the superposed symptoms related to uremia (anorexia,
fatigue, sleep disorders) and the absence of a systematic
psychiatric evaluation (4). Beck’s Depression Inventory (BDI)
is one of the most widely used tests for assessing the severity
of depression in this population and was recently modified
for dialysis patients due to the high prevalence of symptoms
that can mimic the clinical presentation of depression in this
population (5). Unemployment, white race, dialysis vintage,
and female sex are recognized factors associated with
depression in dialysis patients (6,7). Usually, dialysis units
have morning, afternoon, and evening shifts, and patients are
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distributed depending on their own preference. Recent
studies have suggested that dialysis shift may have an
impact on sleep disorders, quality of life, andmortality (8-10).
However, evidence regarding the influence of dialysis shift
on the prevalence of depression is scarce (11).
Therefore, we aimed to evaluate the influence of the
dialysis shift on depression frequency in a population of
patients undergoing hemodialysis. In addition, we assessed
the main outcomes related to depression symptoms and
management and identified possible biochemical markers of
depression in this specific population.
& MATERIALS AND METHODS
This cross-sectional study included patients 18 years of
age or older who were attending a hemodialysis program at
a tertiary hospital. Patients who had undergone less than six
months of dialysis, those with advanced malignancy, and
those who were intellectually unable to answer the ques-
tionnaires or who refused to participate were excluded. The
prevalence of depression symptoms was assessed using
Beck’s Depression Inventory (BDI), which is a questionnaire
that includes 21 queries with graduated answers from 0 to
3 that addresses issues such as sadness, guilt, tiredness,
concern with personal appearance, being able to work,
sexual interest, and other issues (12). Recently, BDI was
validated for CKD patients through a comparison with a
structured psychiatric interview using ICD-10 criteria and
applied by a trained psychiatrist. Based on this study, the
BDI cut-off of 10, which was validated for the general
population, was raised to sixteen or higher for CKD patients
(5). BDI was also validated in dialysis patients against the
Structured Clinical Interview for Diagnostic and Statistical
Manual of Mental Disorders (SCID), and an identical cut-off
was found (13). BDI has already been translated, adapted,
and validated in Brazilian Portuguese, showing good
reliability and validity (14). Excessive daytime sleepiness
(EDS) was also evaluated using the Epworth Sleepiness
Scale (ESS), and patients with values higher than 9 were
considered to have EDS, as described previously (15).
An additional questionnaire was applied to assess general
data (age, gender, scholarship level, marital state, address in
urban or rural area, occupation, cause of CKD, comorbid-
ities, antidepressant drugs, number of hospitalizations in
the last year) and data related to the dialysis session (time
on dialysis, interdialytic weight gain, and single pool Kt/V
[which measures dialysis dose]). Laboratory parameters
were analyzed, such as hemoglobin, calcium, phosphorus,
and albumin. The statistical analysis was performed based
on the median values of the last three months. The patients
were evaluated according to their dialysis shift: morning,
afternoon, or evening.
Ethics
The study was submitted and approved by a local ethics
committee (protocol number 1325), and all subjects pro-
vided written informed consent. This study was performed
in accordance with the Helsinki Declaration of 1975.
Statistical analysis
The data are expressed as the mean¡standard deviation
(SD). For the statistical analysis and data description, patients
were stratified according to dialysis shift (morning, after-
noon, and evening). Numerical variables were submitted to
the Kolmogorov-Smirnov test and compared using ANOVA
with a Bonferroni post-test. The Mann-Whitney test was
performed to analyze variables that were not normally
distributed. Categorical variables were examined by a Chi-
square test. The association between the laboratory data,
demographic data, and the presence of depression was
evaluated by logistic regression (Enter method). The vari-
ables used in the logistic regression model were gender, age,
dialysis vintage, unemployment, dialysis shift, hospitaliza-
tion, rural area, hemoglobin, and phosphorus. The signifi-
cance level adopted was p,0.05 with a 95% confidence
interval. All statistical analyses were performed using SPSS
software (SPSS Inc., Chicago, IL).
& RESULTS
After application of the exclusion criteria, 96 patients
were enrolled during the four months of data collection
(December 2009 to March 2010). Among these patients, 55
were male, and the mean age was 48¡14 years. The main
clinical, demographic, and laboratory characteristics are
summarized in Table 1. Most of the patients were married
(63.5%) and not employed (88.5%). Depression symptoms
and EDS were observed in 41 (42.7%) and 47 (49%) patients,
respectively. The dose of dialysis, expressed as Kt/V, was
adequate for all patients.
There were no differences between individuals in the
three dialysis shifts with respect to age, dialysis vintage,
employment status, hemoglobin, phosphorus, albumin
levels, or EDS (Table 2). Patients in the morning shift lived
farther from the dialysis unit (p,0.0001), in a rural area. The
prevalence of depression was higher among patients in the
morning shift (Table 2).
When comparing patients with and without depression,
we found no difference in gender, dialysis vintage, employ-
ment status, or address in a rural area. The most important
difference in depression prevalence was between indivi-
duals in the morning and evening dialysis shifts (Pearson
Table 1 - Demographic and clinical data (N=96).
Variable Patients (N=96)
Age, years 48.1¡13.7
Male gender, n (%) 55 (57.3)
Marital status
Single, n (%) 17 (17.7)
Married, n (%) 61 (63.5)
Divorced, n (%) 10 (10.4)
Widowed, n (%) 8 (8.3)
Employment
Yes, n (%) 11 (11.5)
No, n (%) 85 (88.5)
Comorbidities
Hypertension, n (%) 74 (77)
Heart failure, n (%) 18 (18.7)
Diabetes mellitus, n (%) 14 (14.5)
Liver disease, n (%) 06 (6.2)
Lupus erythematosus, n (%) 03 (3.1)
Hypothyroidism, n (%) 02 (2)
Dialysis vintage, years 5.1¡3.7
Interdialytic weight gain, kg 2.4¡0.9
Hemoglobin, g/dl 9.9¡1.6
Phosphorus, mg/dl 5.7¡1.5
Albumin, g/dl 3.9¡0.4
Kt/V 1.2¡0.2
Values are expressed as the mean¡SD unless indicated otherwise.
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Chi-Square = 6.20; CI 0.06-0.75; p= 0.015). There was no
difference between morning and afternoon dialysis shifts
(Pearson Chi-Square = 0.85; CI 0.26-1.61; p= 0.37). The
difference between afternoon and evening shifts was
marginally significant (Pearson Chi-Square = 3.07; CI 0.09-
1.17; p= 0.09).
Using the logistic regression model, elderly patients had a
higher risk of depression, as shown in Table 3. Lower levels
of hemoglobin and phosphorus were significantly asso-
ciated with depression symptoms. Depressive patients had
a hospitalization risk that was 4.5 times higher than that
of nondepressive patients (IC 1.48-14.01; p,0.008). Other
variables used in the logistic regression (gender, dialysis
vintage, unemployment, and address in a rural area) were
not associated with depression. Only 19 (19.8%) patients
were being administered the appropriate drug treatment for
depression.
& DISCUSSION
Based on our data, we have shown that the prevalence of
depression symptoms was 42.7%. We found that depression
was associated with dialysis during the morning shift, older
age, lower hemoglobin and phosphate, and a high risk of
hospitalization. The significance of the observed high
frequency of depression becomes more evident if we
compare it with the prevalence of 5% in the general adult
population (16).
In a recent analysis, it was demonstrated that CKD patients
on dialysis had a higher risk of depression than predialysis
patients, with a frequency of depressive symptoms of 34.5%
for the dialysis group vs. 13.3% for the predialysis group (17).
Previous studies have demonstrated a high variability (from
20 to 65%) in the prevalence of depression in dialysis patients
(1,4,6,17,18). This disparity could be the result of different
diagnostic tools or a distinct BDI cut-off. The BDI is one
of the most widely used tests for assessing the severity of
depression. In the general population, the diagnosis of
depression is based on receiving 10 points on the BDI. In
patients with CKD, due to the presence of symptoms that
can mimic the clinical presentation of depression (fatigue,
anorexia, sleep disorders), the cut-off is higher; patients who
score 16 or more points are considered to be depressed, with
a sensitivity and specificity of 92 and 80%, respectively (5). In
our study, we adopted the criteria mentioned above; hence,
our prevalence was similar to the previous analysis with the
same methodology (17,19). Recently, Lossman et al. com-
pared BDI and the Hospital Anxiety and Depression Scale
(HADS) in patients with CKD and depressive symptoms
diagnosed by the Mini International Neuropsychiatric
Interview (MINI) (20). Both the HADS and BDI were
considered valid screening instruments for the diagnosis of
depression in dialysis patients, with no significant difference
between the scales. Therefore, in the last several years, BDI
has been utilized by several authors for the measurement of
depressive symptoms in CKD patients (21-23).
Consistent with previous findings, depressed patients
had lower levels of hemoglobin (23,24). Due to the similarity
between anemia and depressive symptoms, this is likely to
be only a random association.
In our study, we found a strong correlation between low
levels of phosphorus and depression. In fact, low phosphorus
Table 2 - Variables among dialysis shifts.
Morning shift N=39 Afternoon shift N=37 Evening shift N=20 p-value
Age, years 47¡14 48¡15 50¡5.3 0.71
Dialysis vintage, years 5.3¡3.1 4.8¡3.8 5.5¡4.8 0.75
Unemployed, n (%) 35 (89.7) 34 (91.9) 16 (80) 0.38
Hemoglobin, g/dl 9.7¡1.8 10.3¡1.6 10.1¡1.1 0.59
Phosphorus, mg/dl 5.7¡1.6 5.6¡1.5 5.6¡1.3 0.95
Albumin, mg/dl 3.8¡0.3 3.9¡0.5 3.9¡0.5 0.35
EDS, n (%) 18 (46.2) 20 (54.1) 9 (45) 0.73
BDI.16, n (%) 21 (53.8) 16 (43.2) 4 (20) 0.04*
Rural area, n (%) 24 (61.5) 7 (18.9) 0 (0) 0.0001**
Values are expressed as the mean¡SD unless otherwise indicated. EDS, excessive daytime sleepiness; BDI, Beck’s Depression Inventory.
Table 3 - Independent risk factors for depression (logistic regression).
Depressed (n= 41) Non-depressed (n= 55) RR (IC)* p-value
Age, years 50.5¡14 46.3¡13.4 1.05 (1.00-1.10) 0.03
Gender
Male, n (%) 19 (34.5) 36 (65.5) 0.41 (0.13-1.30) 0.13
Female, n (%) 22 (53.7) 19 (46.3)
Dialysis vintage, years 5.0¡3.7 5.3¡3.7 1.00 (0.99-1.01) 0.38
Unemployment, n (%) 38 (92) 43 (78) 0.42 (0.07-2.46) 0.33
Dialysis shift
Morning, n (%) 21 (21.9) 18 (18.8) 7.9 (1.66-37.59 ) 0.009
Afternoon, n (%) 16 (16.7) 21 (21.9) 4.07 (0.90-18.41) 0.068
Evening, n (%) 4 (4.2) 16 (16.7) 1 1
Hospitalizations, n (%) 28 (68.3) 25 (45.5) 4.55 (1.48-14.01) 0.008
Rural area, n (%) 15 (36.6) 16 (29.2) 2.0 (0.53-7.51) 0.30
Hemoglobin, g/dl 9.4¡1.4 10.3¡1.6 0.60 (0.40-0.88) 0.010
Phosphorus, mg/dl 5.2¡1.3 6.1¡1.6 0.50 (0.29-0.85) 0.011
Values are expressed as the mean¡SD unless otherwise indicated. * Relative risk (95% confidence interval). 1 Used as a reference on regression.
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was an independent factor associated with depression.
Moreover, depressive patients also presented a tendency to
have lower albumin levels, which was associated with an
increased risk of depression. These findings suggest that, at
least in the present study, low levels of phosphorus might be
the result of the poor nutritional status of depressed patients,
as previously demonstrated by others (25,26). However, it
must be stressed that this relationship was not clarified in the
present study because an additional assessment of nutritional
status was not performed.
The association between depression and dialysis shift has
not been fully explored in CKD patients. Recently, it has
been determined that patients in the morning dialysis shift
present a higher incidence of depressive symptoms (11). In
the present study, we observed that the risk of depression
was strikingly increased in patients who attended the
morning dialysis shift compared with those who attended
the evening shift. This noticeable advantage of the evening
shift has already been demonstrated for EDS and mortality
(9,10). Taken together, our findings are similar and show a
lower risk of depression among individuals attending the
evening shift; notably, there was no difference in age, time
on dialysis, or employment status among the three dialysis
shifts. It must be noted that in our dialysis unit, patients
who received treatment during the morning shift needed to
wake up rather early because most of them lived far from
the hospital (rural area); thus, it took them a long time to
arrive at the dialysis center. Furthermore, if these patients
waited too long for their dialysis session, they would not
arrive at their houses until the end of the day. In contrast,
most of the patients attending the evening shift lived nearby
and usually did not spend much time traveling home from
the dialysis clinic. Based on this information, is tempting to
speculate that sleep deprivation may influence the higher
incidence of depression observed in those attending the
morning shift. However, we found no differences in EDS
between dialysis shifts. It is noteworthy that the subjective
sleep measurement using the Epworth Scale did not rule out
the presence of sleep disturbances (27). Relatedly, Unruh
et al. demonstrated that the polysomnography sleep time
did not correlate with the self-reported sleep time in dialysis
patients (28). This result can explain the lack of association
between sleepiness assessed by the Epworth Scale and the
morning shift in our data.
It can be argued that living in a rural area, rather than the
morning shift itself, could be associated with depression.
However, in multiple regression analysis, rural area was not
an independent risk factor for depression. Moreover, the
influence of the distance to the dialysis center on variables
such as quality of life and depression has been recently
studied, and distance was not found to have an effect (29).
Despite the high prevalence of depression observed in our
study, less than 20% of depressive patients were receiving
appropriate treatment with antidepressants or alternative
therapies, and most of them were not undergoing periodic
psychiatric monitoring or psychotherapy. Alternative treat-
ments, such as cognitive-behavioral therapy and exercise
programs, have recently been demonstrated to have a
positive impact on the management of depression (30,31);
however, these treatments were not prescribed. Only a
minority of CKD patients with depression are appropriately
treated, especially those who require pharmacologic therapy
(32,33). The main reason for this lack of treatment may be
the absence of controlled trials studying the safety of
antidepressants in this particular population (32,34).
However, serotonin selective reuptake inhibitors have been
used in ESRD patients without any adverse effects requiring
cessation (35).
This study has several strengths. First, to our knowledge,
this is the first study assessing the influence of dialysis shift
on depression as the main objective. Second, we used a well-
validated tool—the BDI—to assess the depression symp-
toms. Third, all patients were examined by the same
observer, diminishing the bias in collecting data. This study
also has several limitations. The design of the study did not
allow us make conclusions based on follow-up or cause-
effect. We could not clarify the association between low
phosphorus and depression, and we were only able to make
an assumption that depression is influenced by nutritional
parameters. The patients were not examined by a psychia-
trist to confirm the clinical diagnosis of depression. Finally,
despite making adjustments to account for differences
among the three dialysis shifts with respect to the address
of the patients (rural or urban area), we could not guarantee
that the beta error was completely eliminated.
In summary, depression is highly prevalent and most
likely misdiagnosed among many CKD patients requiring
dialysis. Despite the high prevalence rates, only a few
patients were being properly treated for depression. The
hospitalization risk in CKD patients increases markedly
with the presence of depression. The most important factors
associated with depression were dialysis shift and lower
levels of phosphorus and hemoglobin. The association
between depression and dialysis in the morning shift
highlights the need for further studies to clarify this
relationship. Sleep deprivation is thus far the most plausible
explanation for our findings.
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